npj Digital Medicine (Mar 2025)

Leveraging electronic medical records to evaluate a computerized decision support system for staphylococcus bacteremia

  • Julia Palm,
  • Ssuhir Alaid,
  • Danny Ammon,
  • Julian Brandes,
  • Andreas Dürschmid,
  • Claudia Fischer,
  • Jonas Fortmann,
  • Kristin Friebel,
  • Sarah Geihs,
  • Anne-Kathrin Hartig,
  • Donghui He,
  • Andrew J. Heidel,
  • Petra Hetfeld,
  • Roland Ihle,
  • Suzanne Kahle,
  • Verena Koi,
  • Margarethe Konik,
  • Frauke Kretzschmann,
  • Henner Kruse,
  • Norman Lippmann,
  • Christoph Lübbert,
  • Gernot Marx,
  • Rafael Mikolajczyk,
  • Anne Mlocek,
  • Stefan Moritz,
  • Christoph Müller,
  • Susanne Müller,
  • Ariadna Pérez Garriga,
  • Lo An Phan-Vogtmann,
  • Diana Pietzner,
  • Mathias W. Pletz,
  • Mario Popp,
  • Maike Rebenstorff,
  • Jonas Renz,
  • Florian Rißner,
  • Rainer Röhrig,
  • Kutaiba Saleh,
  • Sebastian G. Schönherr,
  • Cord Spreckelsen,
  • Anja Stempel,
  • Abel Stolz,
  • Eric Thomas,
  • Susanne Thon,
  • Daniel Tiller,
  • Sebastian Uschmann,
  • Sebastian Wendt,
  • Thomas Wendt,
  • Philipp Winnekens,
  • Oliver Witzke,
  • Stefan Hagel,
  • André Scherag

DOI
https://doi.org/10.1038/s41746-025-01569-3
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Infectious disease specialists (IDS) improve outcomes of patients with Staphylococcus bacteremia, but immediate IDS access is not always guaranteed. We investigated whether a care-integrated computerized decision support system (CDSS) can safely enhance the standard of care (SOC) for these patients. We conducted a multicenter, noninferiority, interventional stepped-wedge cluster randomized controlled trial relying on the data integration centers at five university hospitals. By this means, electronic medical records can be used for part of the trial documentation. We analyzed 5056 patients from 134 wards (Staphylococcus aureus (SAB): n = 812, coagulase-negative staphylococci (CoNS): n = 4244) and found that the CDSS was noninferior to the SOC for hospital mortality in all patients. Noninferiority regarding the 90-day mortality/relapse in SAB patients was not observed and there was no evidence for differences in vancomycin usage among CoNS patients. Despite low reported usage, physicians rated the CDSS’s usability favorably. Trial registration: drks.de; Identifier: DRKS00014320; Registration Date: 2019-05-06.